Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate is a chemical compound belonging to the oxadiazole class, characterized by a molecular formula of C11H9BrN2O4. This derivative features an ethyl ester group, a 4-bromophenyl ring, and a 1,2,4-oxadiazole ring with a carboxylate functional group. The incorporation of a bromine atom and the oxadiazole ring endows this compound with potential applications in organic synthesis and medicinal chemistry, making it a promising candidate for the development of biologically active molecules and further research.

861146-12-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 861146-12-5 Structure
  • Basic information

    1. Product Name: Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate
    2. Synonyms: Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate;XDJVQNUMZNYBSC-UHFFFAOYSA-N
    3. CAS NO:861146-12-5
    4. Molecular Formula: C10H7BrN2O3
    5. Molecular Weight: 297.1
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 861146-12-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate(861146-12-5)
    11. EPA Substance Registry System: Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate(861146-12-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 861146-12-5(Hazardous Substances Data)

861146-12-5 Usage

Uses

Used in Organic Synthesis:
Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate is used as a building block in organic synthesis for the preparation of other biologically active molecules. Its unique structure, including the bromine atom and the oxadiazole ring, allows for the creation of diverse chemical entities with potential applications in various fields.
Used in Medicinal Chemistry:
In the pharmaceutical industry, Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate is used as a starting material for the development of new drugs. Its structural features may contribute to interesting pharmacological properties, making it a valuable candidate for research and development in drug discovery.
Used in Material Science:
Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate may also find applications in material science due to the potential of oxadiazole-based compounds to exhibit specific properties, such as thermal stability and chemical resistance, which can be utilized in the development of advanced materials for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 861146-12-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,1,4 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 861146-12:
(8*8)+(7*6)+(6*1)+(5*1)+(4*4)+(3*6)+(2*1)+(1*2)=155
155 % 10 = 5
So 861146-12-5 is a valid CAS Registry Number.

861146-12-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 3-(4-bromophenyl)-1,2,4-oxadiazole-5-carboxylate

1.2 Other means of identification

Product number -
Other names B-4837

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:861146-12-5 SDS

861146-12-5Relevant articles and documents

Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure–Activity Relationship, X-ray Crystal Structure, and Anticancer Activity

Moniot, Sébastien,Forgione, Mariantonietta,Lucidi, Alessia,Hailu, Gebremedhin S.,Nebbioso, Angela,Carafa, Vincenzo,Baratta, Francesca,Altucci, Lucia,Giacché, Nicola,Passeri, Daniela,Pellicciari, Roberto,Mai, Antonello,Steegborn, Clemens,Rotili, Dante

supporting information, p. 2344 - 2360 (2017/04/01)

Sirt2 is a target for the treatment of neurological, metabolic, and age-related diseases including cancer. Here we report a series of Sirt2 inhibitors based on the 1,2,4-oxadiazole scaffold. These compounds are potent Sirt2 inhibitors active at single-digit μM level by using the Sirt2 substrate a-tubulin-acetylLys40 peptide and inactive up to 100 μM against Sirt1, -3, and -5 (deacetylase and desuccinylase activities). Their mechanism of inhibition is uncompetitive toward both the peptide substrate and NAD+, and the crystal structure of a 1,2,4-oxadiazole analog in complex with Sirt2 and ADP-ribose reveals its orientation in a still unexplored subcavity useful for further inhibitor development. Tested in leukemia cell lines, 35 and 39 induced apoptosis and/or showed anti proliferative effects at 10 or 25 μM after 48 h. Western blot analyses confirmed the involvement of Sirt2 inhibition for their effects in NB4 and in U937 cells. Our results provide novel Sirt2 inhibitors with a compact scaffold and structural insights for further inhibitor improvement.

Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents

dos Santos Filho, José Maurício,de Queiroz e Silva, Diogo Manoel Alves,Macedo, Taís Soares,Teixeira, Helena Mariana Pitangueira,Moreira, Diogo Rodrigo Magalhaes,Challal, Soura,Wolfender, Jean-Luc,Queiroz, Emerson Ferreira,Soares, Milena Botelho Pereira

, p. 5693 - 5701 (2016/11/09)

Malaria, caused by several Plasmodium species, is the major life-threatening parasitic infection worldwide. Due to the parasite resistance to quinoline based drugs, the search for antimalarial agents is necessary. Here, we report the structural design, sy

Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice

Dos Santos Filho, Jose Mauricio,Moreira, Diogo Rodrigo M.,De Simone, Carlos Alberto,Ferreira, Rafaela Salgado,McKerrow, James H.,Meira, Cassio Santana,Guimaraes, Elisalva Teixeira,Soares, Milena Botelho Pereira

, p. 6423 - 6433,11 (2012/12/11)

We recently showed that oxadiazoles have anti-Trypanosoma cruzi activity at micromolar concentrations. These compounds are easy to synthesize and show a number of clear and interpretable structure-activity relationships (SAR), features that make them attr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 861146-12-5